This public procurement contract involves the supply of medicinal products (contrast agents) according to the specifications and conditions outlined in Appendix 2 of the tender documentation (Sample Purchase Agreement) and Appendix 3 (Price Offer) published on the buyer's profile.
Tender closed on 30 Jul 2025. Awaiting award.
No single supplier dominates the field.
In healthcare medical, MASARYK ONCOLOGY INSTITUTE has awarded 6 contracts to 6 suppliers.
Across healthcare medical, the most active winners are URTICA SP Z O O, SALUS INTERNATIONAL SP Z O O, URTICA SP Z OO — the field to beat, or your route in as a partner.
This public procurement contract involves the supply of medicinal products as specified in the attached documents. The contract is divided into five parts according to the specifications provided in the documentation. Suppliers are invited to submit their offers based on the detailed requirements ou
This public procurement contract involves the supply of a theragnostic application system, including necessary accessories and related consumables as specified in Appendix 2 of the tender documentation (contract templates). Additionally, it includes the provision of related supplies and services as
This public procurement contract is for the supply of a genetic analyzer specifically designed for Sanger sequencing and fragment analysis. It includes the provision of related consumables as specified in the relevant appendices of the tender documentation. Suppliers are invited to submit their prop
This public procurement contract involves the supply of a medicinal product, specifically Fludeoxyglucose-(18F), as detailed in the specifications and conditions outlined in attachments 2 (Public Procurement Specifications) and 3 (Sample Purchase Agreement) of the tender documentation. The contract
UK Home Office seeks a global tuberculosis screening service provider to manage visa applicant testing across international locations through various delivery models.
Norfolk County Council is seeking a contractor to provide technology-enabled and virtual care services that help residents maintain independence and improve outcomes while remaining in their own homes.
Market engagement RFI for integrated criminal justice liaison, prison reentry and mental health treatment services across Lancashire and Cumbria, closing 4 September 2026.
UKHSA is seeking supplier participation in a market engagement exercise for Pralidoxime Chloride supply in 2026 through a formal Request for Information process.
